These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2530095)

  • 1. Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat.
    Kelley AE; Lang CG
    Eur J Pharmacol; 1989 Aug; 167(3):385-95. PubMed ID: 2530095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sensitization between cocaine and GBR 12909, a dopamine uptake inhibitor.
    Baldo BA; Kelley AE
    Brain Res Bull; 1991 Jul; 27(1):105-8. PubMed ID: 1834316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies.
    Pileblad E; Engberg G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):383-7. PubMed ID: 2950328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective dopamine uptake inhibitor GBR 12909: its effects on the microstructure of feeding in rats.
    van der Hoek GA; Cooper SJ
    Pharmacol Biochem Behav; 1994 May; 48(1):135-40. PubMed ID: 8029284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake.
    Heikkila RE; Manzino L
    Eur J Pharmacol; 1984 Aug; 103(3-4):241-8. PubMed ID: 6237922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action.
    Andersen PH
    Eur J Pharmacol; 1989 Aug; 166(3):493-504. PubMed ID: 2530094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.
    Howell LL; Byrd LD
    J Pharmacol Exp Ther; 1991 Jul; 258(1):178-85. PubMed ID: 1677037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the ambulation-increasing effect of GBR-12909, a selective dopamine uptake inhibitor, in mice.
    Hirate K; Kuribara H
    Jpn J Pharmacol; 1991 Apr; 55(4):501-11. PubMed ID: 1832199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cocaine and GBR 12935: effects on locomotor activity and stereotypy in two inbred mouse strains.
    Tolliver BK; Carney JM
    Pharmacol Biochem Behav; 1994 Jul; 48(3):733-9. PubMed ID: 7938129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys.
    Skjoldager P; Winger G; Woods JH
    Drug Alcohol Depend; 1993 Jun; 33(1):31-9. PubMed ID: 8370338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated GBR 12909 administration on brain stimulation reward.
    Melnick SM; Maldonado-Vlaar CS; Stellar JR; Trzcińska M
    Eur J Pharmacol; 2001 May; 419(2-3):199-205. PubMed ID: 11426842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cocaine and GBR-12909 on brain stimulation reward.
    Maldonado-Irizarry CS; Stellar JR; Kelley AE
    Pharmacol Biochem Behav; 1994 Aug; 48(4):915-20. PubMed ID: 7972296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward.
    Cunningham ST; Kelley AE
    Brain Res; 1992 Aug; 588(1):104-14. PubMed ID: 1327405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.
    Vaugeois JM; Bonnet JJ; Duterte-Boucher D; Costentin J
    Eur J Pharmacol; 1993 Jan; 230(2):195-201. PubMed ID: 8422901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesencephalic microinjections of neurotensin-(1-13) and its C-terminal fragment, neurotensin-(8-13), potentiate brain stimulation reward.
    Rompré PP; Gratton A
    Brain Res; 1993 Jul; 616(1-2):154-62. PubMed ID: 8358607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.